FKGK18 is a selective group VIA calcium-independent phospholipase A2 (GVIA iPLA2) inhibitor. FKGK18 is a fluoroketone (FK)-based compound with IC50s of 50 nM and 3 µM for iPLA2beta and iPLA2gamma. FKGK18 can be used for the research of beta-cell apoptosis and diabetes[1][2][3].
Molecular Weight:
280.28
Purity:
99.90
CAS Number:
[1071001-09-6]
Formula:
C16H15F3O
Target:
Apoptosis,Phospholipase
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
